Phase IB Trial of Radium-223 and Niraparib in Patients with Castrate Resistant Prostate Cancer

Grant

Date/time Interval

  • September 17, 2018 - September 16, 2023
  • Total Award Amount

  • 272371.00
  • Direct Costs

  • 209516.00
  • Sponsor Award Id

  • Contributor

  • Yang M.D., Ph.D., Eddy   Principal Investigator